Larson Financial Group’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $58 | Buy |
+79
| New | +$58 | ﹤0.01% | 3195 |
|
|
2025
Q1 | – | Sell |
-147
| Closed | -$203 | – | 3068 |
|
|
2024
Q4 | $203 | Hold |
147
| – | – | ﹤0.01% | 2426 |
|
|
2024
Q3 | $153 | Sell |
147
-71,343
| -100% | -$74.3K | ﹤0.01% | 2428 |
|
|
2024
Q2 | $124K | Sell |
71,490
-2,471
| -3% | -$4.28K | 0.01% | 591 |
|
|
2024
Q1 | $177K | Buy |
73,961
+73,814
| +50,214% | +$176K | 0.01% | 437 |
|
|
2023
Q4 | $490 | Hold |
147
| – | – | ﹤0.01% | 1577 |
|
|
2023
Q3 | $550 | Buy |
+147
| New | +$550 | ﹤0.01% | 1568 |
|
|
2023
Q2 | – | Sell |
-27,409
| Closed | -$187K | – | 1574 |
|
|
2023
Q1 | $187K | Buy |
+27,409
| New | +$187K | 0.02% | 318 |
|